Lisa Heather Group giving a nice overview on posttranslational modifications by metabolic intermediates in diabetes and other CV diseases COST Action EU-METAHEART meeting. Much more in metabolism than just ATP! Gabriele G. Schiattarella ISHR European Section Basic Research in Cardiology

📃📣 📣📣September news! ➡️Great success for our 1st Training School in Wurzburg on Oroboros Instruments, Seahorse & IonOptix with 18 students & postdocs ➡️ International conference with 4 awardees for their great presentation: Angeliki Dajou, Hualin Fan, Matus Miklovic & David Weissman

⚠️⚠️📢📢IMPORTANT NEWS!!! our Website is now ON!!! Please take a look⤵️ EU-METAHEART | COST Action CA22169 – EUropean network to tackle METAbolic alterations in HEART failure (cost-metaheart.eu) to find out news, job opportunities & more💡🔍

The Medical University of Graz (Austria) is opening a position of Tenure Track Professor of Sex and Gender-dependent Mechanisms in the Pathophysiology of Cardio-metabolic Disease Application via their online job portal medunigraz.at/en/job-opening… Application deadline: 7 November 2024

📢📢📢SAVE THE DATE!!! WG2 webinar on December 10th 2024 – 5PM CET on microvascular dysfunction in Takotsubo & HF, & sex-specific differences To join: Zoom meeting-ID: 912 1197 3978 Password: 991198 more info⤵️⤵️⤵️⤵️

🔊🔊🔊Call for Short-term scientific mission (STSM) open from Monday, November 25th until December 9th, 2024 🎓You are a Young Research Innovator? You want to visit another lab from COST Action EU-METAHEART? 📝Apply for a grant up to 2k€ More info: cost-metaheart.eu/news/call-for-…

📢New Research Highlight from COST Action EU-METAHEART consortium “Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage” by Panagiota-Efstathia Nicolau, Ioanna Andreadou & collaborators⤵️ sciencedirect.com/science/articl…

📣📣📣A comprehensive overview on the multifaceted mechanisms driving cardiac amyloidosis led by COST Action EU-METAHEART Core members Luca Liberale Christoph Maack Petra Kleinbongard ⏩link.springer.com/article/10.100…

📢📢📢3rd meeting of the management committee (MC3) of our COST Action EU-METAHEART COST Action on March 19 and 20, 2025 ➡️➡️➡️ please join online 👍Program and how to join online: cost-metaheart.eu/news/program-o…

In review #1, Mathias Mericskay et al. discuss dysregulated substrate & intermediary metabolism and its role for post-translational modifications in #heartfailure (HFpEF&rEF). W/contr by Gabriele G. Schiattarella Heather Group Luc Bertrand Anja Karlstaedt nature.com/articles/s4156…

In article #2, Luca Liberale Petra Kleinbongard et al. review the central role of coronary &systemic vascular dysfunction in #heartfailure (pEF&rEF), providing a mechanistic framework for therapies targeting the vasculature in different HF phenotypes. nature.com/articles/s4156…

In review #3, Gemma Vilahur Alessandra Ghigo et al. discuss how the interplay between #inflammation & #metabolism drives #heartfailure progression across etiologies & along the EF spectrum. In loving memory of Ioanna Andreadou academic.oup.com/eurheartj/arti…. nature.com/articles/s4156…

Finally, in review #4 Dunja Aksentijevic Ricciarelli Simon Sedej Paillard Mélanie Katrin Streckfuss-Bömeke EdoardoBertero Jeremy Fauconnier et al discuss how the imbalance between mechanical load and mitochondrial ATP supply induces a redox mismatch that drives #heartfailure progression. nature.com/articles/s4156…

All 4 reviews are OPEN ACCESS for 1 month at nature.com/nrcardio/. Special thanks to the team of Nature Reviews Cardiology, in particular Dr. Gregory Lim! Please also visit our website cost-metaheart.eu & become member at cost.eu/actions/CA2216…. SFB1525 Cardio-Immune Interfaces Universität Würzburg #UniWürzburg Deutsches Zentrum für Herzinsuffizienz